Gao Jieyu, Zhang Qianqian, Lv Nan, Li Qiang, Gu Yuxiang, Xu Liquan, Huang Chuangren, Mao Guohua, Lu Hua, Zhong Shu, Duan Chuanzhi, Xie Xiaodong, Wan Jieqing, Wang Feng, Guan Sheng, Shao Qiuji, Chang Kaitao, Ding Jinyi, Lei Yingbo, Li Tianxiao, Lv Ming, Li Li, Liu Jianmin
Department of Cerebrovascular Disease, Henan University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
Department of Cerebrovascular Disease, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
J Neurointerv Surg. 2025 Apr 23. doi: 10.1136/jnis-2025-023241.
The optimal selection of stent size remains uncertain. This study evaluated the impact of stent diameter on in-stent stenosis (ISS) after interventional therapy through a subgroup analysis of the Intracranial Aneurysms Managed by Parent Artery Reconstruction Using Tubridge Flow Diverter (IMPACT) trial.
This prospective, multicenter study included patients treated with the Tubridge Flow Diverter (TFD) at 14 centers between December 16, 2019 and October 26, 2022. The primary outcome was the incidence of ISS at the 12-month follow-up. We analyzed the effect of different stent sizes on ISS in all patients from IMPACT who had follow-up imaging. The parent artery was divided into proximal and distal vessels, and we introduced the ratio of diameter (RD) as a parameter to assess the association between stent diameter and vessel diameter.
A total of 167 patients with 195 intracranial aneurysms were included. ISS was classified as mild (<25%) in 9 cases (5.4%), moderate (25-50%) in 4 cases (2.4%), severe (51-75%) in 1 case (0.6%), and extremely severe (>75%) in 5 cases (3%). A total of 390 proximal and distal vessels were evaluated, with a mean RD of 1.14±0.26. Smaller parent artery diameter and higher RD were significantly associated with ISS (p=0.002 and p=0.021, respectively). Additionally, the risk of ISS increased when RD>1.1 (p=0.006).
In TFD treatment for intracranial aneurysms, stent size and the diameters of proximal and distal parent arteries should be carefully considered, especially in cases involving small parent arteries. Maintaining an RD of less than 1.1 may reduce the risk of ISS.
支架尺寸的最佳选择仍不确定。本研究通过对使用 Tubridge 血流导向装置进行载瘤动脉重建治疗颅内动脉瘤(IMPACT)试验的亚组分析,评估了支架直径对介入治疗后支架内狭窄(ISS)的影响。
这项前瞻性、多中心研究纳入了 2019 年 12 月 16 日至 2022 年 10 月 26 日期间在 14 个中心接受 Tubridge 血流导向装置(TFD)治疗的患者。主要结局是 12 个月随访时 ISS 的发生率。我们分析了 IMPACT 中所有有随访影像的患者中不同支架尺寸对 ISS 的影响。将载瘤动脉分为近端和远端血管,并引入直径比(RD)作为参数来评估支架直径与血管直径之间的关联。
共纳入 167 例患有 195 个颅内动脉瘤的患者。ISS 分类为轻度(<25%)9 例(5.4%),中度(25 - 50%)4 例(2.4%),重度(51 - 75%)1 例(0.6%),极重度(>75%)5 例(3%)。共评估了 390 条近端和远端血管,平均 RD 为 1.14±0.26。较小的载瘤动脉直径和较高的 RD 与 ISS 显著相关(分别为 p = 0.002 和 p = 0.021)。此外,当 RD>1.1 时,ISS 的风险增加(p = 0.006)。
在 TFD 治疗颅内动脉瘤时,应仔细考虑支架尺寸以及近端和远端载瘤动脉的直径,尤其是在涉及小载瘤动脉的情况下。保持 RD 小于 1.1 可能会降低 ISS 的风险。